Healthcare provider profile · identity verified

Bula Roy, MD

Internal Medicine · COON RAPIDS, MN · NPI 1548220007

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	564	139
Atorvastatin Calcium	Atorvastatin Calcium	534	146
Omeprazole	Omeprazole	441	141
Lisinopril	Lisinopril	422	112
Amlodipine Besylate	Amlodipine Besylate	296	84
Losartan Potassium	Losartan Potassium	275	81
Rosuvastatin Calcium	Rosuvastatin Calcium	238	70
Gabapentin	Gabapentin	228	81
Furosemide	Furosemide	209	74
Metoprolol Succinate	Metoprolol Succinate	177	55
Metformin Hcl	Metformin Hcl	162	44
Trazodone Hcl	Trazodone Hcl	156	50
Pantoprazole Sodium	Pantoprazole Sodium	155	47
Prednisone	Prednisone	152	98
Montelukast Sodium	Montelukast Sodium	148	45
Simvastatin	Simvastatin	146	42
Famotidine	Famotidine	141	45
Atenolol	Atenolol	140	38
Metoprolol Tartrate	Metoprolol Tartrate	138	33
Tizanidine Hcl	Tizanidine Hcl	138	43
Fluticasone Propionate	Fluticasone Propionate	136	63
Albuterol Sulfate Hfa	Albuterol Sulfate	135	67
Potassium Chloride	Potassium Chloride	134	41
Pravastatin Sodium	Pravastatin Sodium	129	36
Escitalopram Oxalate	Escitalopram Oxalate	119	35
Warfarin Sodium	Warfarin Sodium	97	29
Ezetimibe	Ezetimibe	91	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	25
Metformin Hcl Er	Metformin Hcl	87	26
Tamsulosin Hcl	Tamsulosin Hcl	82	22
Ipratropium Bromide	Ipratropium Bromide	81	52
Ozempic	Semaglutide	79	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	79	24
Duloxetine Hcl	Duloxetine Hcl	78	22
Triamcinolone Acetonide	Triamcinolone Acetonide	78	54
Sertraline Hcl	Sertraline Hcl	76	22
Eliquis	Apixaban	75	22
Hydrochlorothiazide	Hydrochlorothiazide	71	21
Doxycycline Hyclate	Doxycycline Hyclate	69	59
Cephalexin	Cephalexin	68	45
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	19
Paroxetine Hcl	Paroxetine Hcl	64	15
Allopurinol	Allopurinol	61	17
Clopidogrel	Clopidogrel Bisulfate	60	22
Synthroid	Levothyroxine Sodium	60	15
Mirtazapine	Mirtazapine	59	19
Trulicity	Dulaglutide	59	suppressed
Buspirone Hcl	Buspirone Hcl	58	19
Hydralazine Hcl	Hydralazine Hcl	56	14
Glimepiride	Glimepiride	55	17
Hydroxyzine Hcl	Hydroxyzine Hcl	53	14
Citalopram Hbr	Citalopram Hydrobromide	50	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	49	17
Glipizide	Glipizide	47	12
Fluoxetine Hcl	Fluoxetine Hcl	46	13
Propranolol Hcl Er	Propranolol Hcl	45	11
Carvedilol	Carvedilol	44	13
Glipizide Er	Glipizide	43	11
Jardiance	Empagliflozin	42	12
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	11
Meclizine Hcl	Meclizine Hcl	40	18
Nystatin	Nystatin	40	17
Spironolactone	Spironolactone	38	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	36
Methocarbamol	Methocarbamol	37	15
Fluconazole	Fluconazole	36	25
Valacyclovir	Valacyclovir Hcl	36	25
Xarelto	Rivaroxaban	36	13
Esomeprazole Magnesium	Esomeprazole Magnesium	35	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	11
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	11
Celecoxib	Celecoxib	34	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	34	suppressed
Amoxicillin	Amoxicillin	33	28
Nitroglycerin	Nitroglycerin	33	26
Donepezil Hcl	Donepezil Hcl	30	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Azithromycin	Azithromycin	29	24
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Finasteride	Finasteride	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Estradiol	Estradiol	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	13
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	17
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Ondansetron Odt	Ondansetron	20	13
Methylprednisolone	Methylprednisolone	19	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Ketoconazole	Ketoconazole	17	12
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Febuxostat	Febuxostat	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Enoxaparin Sodium	Enoxaparin Sodium	15	suppressed
Metronidazole	Metronidazole	15	11
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	12
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Niacin Er	Niacin	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Nystop	Nystatin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error